Sorensis Pty Ltd
Dr Kim Agnew - CEO/Founder, Dr Rob Hunter - CSO Background polymer technology developed by Pendant BioSciences (Shawn Glinter CEO/Founder). Sorensis will introduce next generation polymer technology into the Animal Health industry which will provide an unparalleled level of tunable functionality in matching polymer matrix to the API (Active Pharmaceutical Ingredient). Slow-release technology has enormous potential to improve owner compliance with medications, allow therapeutic levels of selected actives to be maintained for extended periods and offer novel delivery systems into hard to effectively medicate spaces (e.g eyes, joints). Sorensis is species agnostic but we do have specific expertise either in house or externally available in bovine, canine, feline and equine.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Sorensis Pty Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Sorensis Pty Ltd
1 distinct titles indexed · top 1 shown.
- 1founder director
Sign up to unlock all 1 contacts at Sorensis Pty Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Sorensis Pty Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.